covid-19-drugkeywords

News about "COVID 19 Drug"

WHO releases guidelines to help countries maintain essential health services during the COVID-19 pandemic

WHO releases guidelines to help countries maintain essential health services during the COVID-19 pandemic

The COVID-19 pandemic is straining health systems worldwide. The rapidly increasing demand on health facilities and health care workers threatens to leave some health systems overstretched and unable to operate effectively

COVID 19 Drug | 01/04/2020 | By Darshana

Researchers at University of Hyderabad find potential solution to develop vaccine for COVID-19 at faster pace

Researchers at University of Hyderabad find potential solution to develop vaccine for COVID-19 at faster pace

With more than 7 lakh people across the globe infected and nearly 38,000 people killed due to the highly infectious and deadly coronavirus, the Hyderabad-based researchers from University of Hyderabad (UoH) have come out with a potential solution that could lead to the development of a vaccine at a faster pace than anticipated by the scientists

COVID 19 Drug | 01/04/2020 | By Darshana

Abbott Launches Molecular Point-Of-Care Test, ID NOW COVID-19 Tests to Detect Coronavirus in as Little as 5 Minutes

Abbott Launches Molecular Point-Of-Care Test, ID NOW COVID-19 Tests to Detect Coronavirus in as Little as 5 Minutes

Abbott announced that the US Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes

COVID 19 Drug | 30/03/2020 | By Darshana

Genentech gets US FDA nod to begin clinical trial for Actemra to treat hospitalized patients with severe COVID-19 pneumonia

Genentech gets US FDA nod to begin clinical trial for Actemra to treat hospitalized patients with severe COVID-19 pneumonia

Genentech, a member of the Roche Group, announced the US Food & Drug Administration (FDA) has approved a randomized, double-blind, placebo-controlled phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) to evaluate the safety and efficacy of intravenous Actemra (tocilizumab) plus standard

COVID 19 Drug | 26/03/2020 | By Darshana


We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology